ELVN · Enliven Therapeutics, Inc. · Debt
Market Cap
$4.35B
Shares
73.27M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1672619
CUSIP
29337E102
13F (30d)
167 filings
167 filers
Visit website
Investor relations